Next-Generation Retisert R&D Efforts Under Way, Bausch & Lomb Says

Bausch & Lomb anticipates that its Retisert drug-delivery eye implant will receive FDA approval for treating non-infectious posterior uveitis by the end of 2004, with U.S. commercialization to begin next year